Viewing Study NCT04690595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-01-05 @ 6:31 PM
Study NCT ID: NCT04690595
Status: RECRUITING
Last Update Posted: 2025-07-31
First Post: 2020-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
Sponsor: PeproMene Bio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B cell View
None ALL View
None relapsed or refractory View